Insulet (PODD) Net Equity Issued and Repurchased (2010 - 2019)

Insulet (PODD) posted Net Equity Issued and Repurchased of -$9.1 million for Q2 2019, down 200.0% on a QoQ basis from $9.1 million in Q1 2019, and down 209.9% year-over-year from $8.2 million in Q2 2018.

Insulet (PODD) Net Equity Issued and Repurchased (2010 - 2019) Analysis & Trends

Insulet's Net Equity Issued and Repurchased history runs 10 years deep, the most recent figure standing at -$9.1 million for Q2 2019.

  • Quarterly Net Equity Issued and Repurchased fell 209.9% year-over-year to -$9.1 million in Q2 2019, while the trailing twelve-month figure through Sep 2020 was -$9.1 million (up 32.7% YoY) and the FY2020 annual result came in at $477.5 million, changed N/A from the prior year.
  • Net Equity Issued and Repurchased was -$9.1 million for Q2 2019 at Insulet, down from $9.1 million in the prior quarter.
  • Across five years, Net Equity Issued and Repurchased topped out at $9.1 million in Q1 2019 and bottomed at -$13.5 million in Q4 2018.
  • A 5-year average of $1.4 million and a median of $1.6 million in 2015 frame the typical range for Net Equity Issued and Repurchased.
  • Annual changes were most pronounced in 2017 — Net Equity Issued and Repurchased jumped 695.85% — and 2019, when it tumbled 209.9%.
  • Insulet's Net Equity Issued and Repurchased stood at $808000.0 in 2015, then sank by 99.26% to $6000.0 in 2016, then soared by 47300.0% to $2.8 million in 2017, then tumbled by 573.42% to -$13.5 million in 2018, then jumped by 32.7% to -$9.1 million in 2019.
  • Business Quant data shows PODD's Net Equity Issued and Repurchased at -$9.1 million in Q2 2019, $9.1 million in Q1 2019, and -$13.5 million in Q4 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn -
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn -
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn 97.00 Mn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn -
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn 12.70 Mn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn -
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn -
10 Insulet 11.52 Bn 11.04 Bn 529.10 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2019 -9.06 Mn
Jun 30, 2019 -9.06 Mn
Mar 31, 2019 9.06 Mn
Mar 31, 2019 9.06 Mn
Dec 31, 2018 -13.46 Mn
Dec 31, 2018 -13.46 Mn
Sep 30, 2018 2.26 Mn
Sep 30, 2018 2.26 Mn
Jun 30, 2018 8.25 Mn
Jun 30, 2018 8.25 Mn
Mar 31, 2018 2.96 Mn
Mar 31, 2018 2.96 Mn
Sep 30, 2017 2.84 Mn
Sep 30, 2017 2.84 Mn
Jun 30, 2017 1.56 Mn
Jun 30, 2017 1.56 Mn
Mar 31, 2017 6.34 Mn
Mar 31, 2017 6.34 Mn
Dec 31, 2016 6,000.00
Dec 31, 2016 6,000.00